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This review focuses on the surface modiﬁcation of substrates with self-assembled monolayers
SAMs and polymer brushes to tailor interactions with biological systems and to thereby enhance
their performance in bioapplications. Surface modiﬁcation of biomedical implants promotes
improved biocompatibility and enhanced implant integration with the host. While SAMs of
alkanethiols on gold substrates successfully prevent nonspeciﬁc protein adsorption in vitro and can
further be modiﬁed to tether ligands to control in vitro cell adhesion, extracellular matrix assembly,
and cellular differentiation, this model system suffers from lack of stability in vivo. To overcome this
limitation, highly tuned polymer brushes have been used as more robust coatings on a greater
variety of biologically relevant substrates, including titanium, the current orthopedic clinical
standard. In order to improve implant-bone integration, the authors modiﬁed titanium implants with
a robust SAM on which surface-initiated atom transfer radical polymerization was performed,
yielding oligoethylene glycol methacrylate brushes. These brushes afforded the ability to tether
bioactive ligands, which effectively promoted bone cell differentiation in vitro and supported
signiﬁcantly better in vivo functional implant integration. © 2009 American Vacuum
Society. DOI: 10.1116/1.3089252
I. INTRODUCTION: MODIFICATION OF SYNTHETIC
SURFACES TO MIMIC BIOLOGICAL
FUNCTIONS
Silicone, titanium, Teﬂon, and stainless steel have found
widespread use in medical implants. However, these materi-
als elicit inﬂammatory responses, including a foreign body
response and ﬁbrous encapsulation, which lead to suboptimal
integration and biological performance of the implanted
device.1–5 Following implantation, synthetic materials un-
dergo dynamic adsorption of proteins and other biomolecules
which induce inﬂammatory cell responses.6 While coatings
and other treatments have been developed to address these
limitations, many materials still provide little control over
the adsorption of proteins and other biomacromolecules that
occurs upon contact with biological ﬂuids. This work led to a
new paradigm in biomaterials research which focuses on
methods to control the presentation of biomacromolecules
and cells onto the surfaces of materials. This is achieved, in
part, by the development of biomimetic materials which
present bioligands within a protein-adsorption resistant non-
fouling background.7–10
Adhesion of cells to a substrate is a complex process that
involves protein adsorption to a surface and presentation of
speciﬁc peptide sequences “adhesion sequences”. Upon im-
plantation of medical devices, proteins such as ﬁbrinogen
and immunoglobulins are nonspeciﬁcally adsorbed from
physiological ﬂuids onto the material surface, Fig. 1.11–13 Re-
ceptors on cell surfaces, called integrins, are transmembrane
proteins that adhere to speciﬁc peptide sequences presented
by the adsorbed proteins. Binding to the integrin triggers a
number of cellular responses which subsequently control in-
ﬂammation, tissue formation, and incorporation of the im-
plant into the host.14–16 Surfaces can experience rapid, non-
speciﬁc, and reversible adsorption of proteins which may
give rise to uncontrolled cell adhesion. Factors that inﬂuence
cell adhesion to substrates include the density of adsorbed
protein and the spatial relationship between synergistic adhe-
sion sequences.17–22 In addition, the composition and density
of the biomolecules on the surface may change dynamically
due to competitive adsorption and rearrangement the “Vro-
man effect” and by cell-mediated protein deposition and re-
organization. Conformational changes may lead to denatur-
ing and loss of biological activity of the protein.23 Thus, it is
highly desirable to attain control over the manner in which
proteins adsorb onto substrates through the molecular design
of interfaces.
Attempts to control cellular responses by the development
of biomimetic materials have focused on presentation of bio-
active peptide sequences. These sequences mimic the func-
tions of biological molecules found in the extracellular ma-
trix ECM. However, these approaches often do not address
the issue of nonspeciﬁc protein adsorption, the density of
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adhesive peptides on the surface, or the importance of dy-
namic nature that is essential to formation and function of
the ECM.7–10
The ECM consists of a complex network of proteins and
polysaccharides that are secreted and arranged by cells.24
Since the ECM is a key structural and functional component
of tissues, it continually undergoes changes to ensure main-
tenance of its structure and presentation of growth factors
and adhesion sequences such as those in collagen COL and
ﬁbronectin FN. Structural proteins such as COL and elastin
form a matrix which provides structural support for cells.
Other components provide cues for signaling cell regulation,
migration, and proliferation,24–31 thereby inﬂuencing tissue
development, blood clotting, wound healing, and cancer
metastasis.32–35 These features motivate research whereby
new biomaterials are designed that present speciﬁc peptide
sequences as a mimic of the ECM.
One of the most widely studied and well-characterized
ECM proteins is FN.36–39 The plasma form of FN is a gly-
coprotein consisting of two 220 kDa subunits that are con-
nected by disulﬁde bonds. FN is soluble in blood plasma and
is assembled into the ECM to form insoluble ﬁbrils by cre-
ation of a multimer.40 This process requires that cells be ad-
hered to the ECM and integrin receptors participate in the
organization of FN into the ﬁbrils.41 FN ﬁbrils in the ECM
regulate many cell functions such as gene expression, cell
cycle progression, and differentiation. FN ﬁbrils are respon-
sible for assembling other proteins in the ECM, and they
play central roles in embryonic development, tissue forma-
tion, homeostasis, and repair.42,43
Proteins in the ECM contain sequences which promote
cell adhesion. These include arginine-glycine-aspartic
acid44 RGD in FN and glycine-phenylalanine-
hydroxyproline-glycine-glutamate-arginine45,46 GFOGER
in COL. RGD is a ubiquitous cell binding sequence. Many
integrin receptors recognize this sequence, thereby facilitat-
ing adhesion of many cell types to FN in the ECM.44 COL is
abundant in mesenchymal tissues and the GFOGER se-
quence promotes cell adhesion and osteoblast
differentiation.47 An understanding of the ability of these ad-
hesive sequences to exert control over cell adhesion provides
an opportunity to design biomimetic materials for medical
implants and thereby promote better incorporation of the de-
vice into the host.
Modiﬁcation of the surfaces of materials used in medical
applications by adsorption or covalent tethering of adhesive
peptides such as RGD and GFOGER promotes cell adhesion
and migration.48–51 However, further consideration must also
be given to the density and spatial arrangement of adhesion
peptides.52–56 In FN, the RGD adhesion sequence is located
in close proximity to a synergistic proline-histidine-serine-
arginine-asparagine PHSRN sequence. This synergistic
binding site enhances integrin receptor binding speciﬁcity
and afﬁnity and aids in the promotion of cell adhesion,
spreading, and differentiation.57–63 Thus, modiﬁcation of sur-
faces with short peptide sequences that contain RGD but do
not provide the synergistic site suffers from decreased bio-
logical activity.64–66
While a great deal of success has been achieved in mim-
icking some of the functions of the ECM, it is clear that the
development of biomaterials which possess the complex
functionality of the ECM remains elusive. For example, little
research has focused on the design of materials that promote
the complex processes involved in the cell-mediated assem-
bly of protein matrices. Thus, we have developed a number
of methods to impart metallic surfaces gold in model sys-
tems and titanium in studies directed toward the develop-
ment of new bone implants with resistance to nonspeciﬁc
adsorption of proteins and by subsequently functionalizing
the surface by covalently attaching an adhesive peptide se-
quence, such as RGD or GFOGER, cell adhesion and differ-
entiation can be directed to elicit speciﬁc responses to en-
hance integration of the implant into the host.
II. SELF-ASSEMBLED MONOLAYERS AS MODELS
FOR BIOLOGICAL INTERFACES
A. Self-assembled monolayers
A self-assembled monolayer SAM is formed when mol-
ecules in solution or the vapor phase adsorb and spontane-
ously organize into a single layer on a surface. SAMs are
formed by adsorption of a variety of functional organic mol-
ecules onto suitable solid substrates. Alkanethiols assemble
on gold,67–70 silver,71,72 copper,73 palladium,74 and
platinum75,76 to provide densely packed molecular monolay-
ers, Fig. 2A. Other combinations of adsorbates and sub-
strates include chlorosilanes on silicon oxide,77,78
aluminum,79 and titanium;80 phosphonic acids on
aluminum79 or titanium;81,82 and catechol derivatives on
titanium.83 Although alkanethiol SAMs on gold are most
commonly studied, they suffer from instability of the thiol-
gold bond leading to facile exchange of the adsorbates. Ad-
sorption of trichlorosilanes on a variety of oxide surfaces is
irreversible, but traces of water lead to the deposition of
ill-deﬁned multilayers through formation of siloxane link-
ages Si–O–Si.84,85 Use of a monochlorosilane avoids this
complication, Fig. 2B.
FIG. 1. Color online Proteins undergo conformational changes upon ad-
sorption to a synthetic substrate, thereby exposing adhesion sequences
which mediate cell adhesion.
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B. Controlled adsorption of proteins on self-
assembled monolayers
SAMs of alkanethiols on gold provide suitable systems to
explore the effects of surface chemistry on protein
adsorption,86–89 albeit these are largely restricted to in vitro
analyses owing to the long-term instability of these assem-
blies. Long-chain alkanethiols bearing a terminal functional
group i.e., HS– CH2n–X, where n10 spontaneously as-
semble onto gold to form densely packed and ordered mono-
layers, Fig. 2C.86,90–92 The physicochemical properties of
the monolayers are determined by the identity of the terminal
functionality of the adsorbate,93,94 as demonstrated, for ex-
ample, by its effect on wetting.95–98 Recently, SAMs have
also been used as model systems for the design of
biosensors67,99–102 and nanoscale switchable surfaces.103,104
The simplicity of creating surfaces presenting a wide range
of chemistries makes the use of SAMs an attractive approach
to study interfacial interactions for numerous applications.
The deposition of SAMs has been studied extensively as a
method to control interactions between solid substrates and
biological systems, including the inﬂuence of surface chem-
istry on protein adsorption105–110 and cell adhesion.111–115 For
example, SAMs of thiols bearing terminal carbohydrates
e.g., Fig. 2C, X=agarose or mannitol prevent protein ad-
sorption and cell adhesion to gold substrates for up to 25
days in vitro.69,105
Alkanethiol SAMs with an oligoethylene glycol OEG
chain at the termini prevent protein adsorption and cell
adhesion.67–69,71,107,116 For example, monolayers of
HS– CH211– OCH2CH2n–OH abbreviated EGn, where
n=3,6, have been studied extensively, Fig. 3. The amount of
protein adsorption to gold substrates modiﬁed with mixed
SAMs consisting of EGn and an unfunctionalized alkanethiol
coadsorbate is a function of the density of EGn adsorbates
and the length of the terminal OEG oligomers.117 Longer
EGn SAMs, e.g., n=6, prevent protein adsorption, whereas
shorter EGn chains do not. The ratio of EGn and unfunction-
alized alkanethiol coadsorbates in mixed monolayers can be
controlled by varying the relative amounts of EGn and al-
kanethiol in the solution in which the gold substrate is im-
mersed. Mixed monolayers with a high proportion of EGn
prevent protein adsorption. In general, a SAM composed of
50% EGn, where n3, is required to impart resistance to
protein adsorption, whereas gold substrates modiﬁed with
only CH3-terminated SAMs readily adsorb proteins thereby
allowing cell adhesion, Fig. 3B.117,118 This can be attributed
to hydrogen bonding between the EGn units and water,
thereby forming a highly hydrophilic monolayer that pre-
vents protein adsorption.67–69,107,116,119
Zhu et al. used surface plasmon resonance SPR to show
that gold substrates modiﬁed with SAMs of EGn do not com-
pletely prevent protein adsorption. These studies showed that
proteins are reversibly adsorbed; they are removed upon rins-
ing the substrate with water.120 To explore this further, Ca-
padona et al. quantiﬁed the adsorption of radiolabeled FN on
mixed SAMs of methyl-terminated e.g., alkanethiol and
FIG. 2. Color online Self-assembled monolayers. A Alkanethiols on gold substrate. B Alkyl silane monolayer formed by treatment of oxidized silicon
surface with alkylchlorodimethylsilane. C -functionalized alkanethiol on gold.
FIG. 3. Color online Self-assembled monolayers of alkanethiols on gold:
A Gold substrate modiﬁed with an oligoethylene glycol-terminated al-
kanethiol, EGn. B A simple unfunctionalized methyl-terminated al-
kanethiol monolayer. C Substrates modiﬁed with CH3-terminated SAMs
allow cell adhesion and surfaces modiﬁed with mixed EG3- and
CH3-terminated SAMs resist cell adhesion.
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EG3.107 Since FN mediates cell adhesion to surfaces, quanti-
fying the amount of FN on the surface and determining con-
ditions under which this can be controlled provides a method
to tailor the amount of cell adhesion to the surface. After
incubation of mixed-alkanethiol SAMs on gold substrates in
radiolabeled FN for 1 h the substrates were incubated in
solutions of either phosphate buffered saline PBS or 10%
newborn calf serum in Dulbecco’s modiﬁed eagle’s medium
for 1 or 16 h, and the amount of FN on the surface was
quantiﬁed. These experiments showed that FN adsorbs to all
surfaces modiﬁed with SAMs of EG3, albeit at low densities,
but that the FN is more easily removed from the substrates
modiﬁed with a greater proportion of EG3. Adsorbed FN was
not eluted from surfaces consisting of only methyl
CH3-terminated alkanethiols after incubation in PBS for up
to 16 h. Similarly, FN adsorbed to substrates presenting a 1:1
mixed monolayer of CH3- and EG3-terminated SAMs could
not be removed after incubation in PBS. Adsorbed FN could
be eluted in signiﬁcant quantities from surfaces presenting
only EG3-terminated alkanethiols on gold, and after incuba-
tion in PBS for 16 h no FN was detected on the surface.
The inﬂuence of FN adsorption on cell adhesion to gold
substrates modiﬁed with mixed monolayers with increasing
amounts of EG3 was also examined. Gold substrates modi-
ﬁed with a mixed monolayer were incubated in FN for 1 h
and then challenged with cells. Greater FN adsorption on
gold substrates modiﬁed with SAMs presenting a smaller
amount of EG3 correlated with an increase in ﬁbroblast ad-
hesion. Substrates presenting only EG3-terminated SAMs ad-
sorbed FN, but upon subsequent incubation in PBS or 10%
serum only background levels of cell adhesion were ob-
served. Surfaces modiﬁed with a 1:1 ratio of CH3- and
EG3-terminated SAMs on gold substrates that were incu-
bated in media prior to being challenged with cells showed a
decrease in cell adhesion after a gentle rinse with PBS.
Lastly, gold surfaces consisting of only methyl-terminated
adsorbates showed high levels of cell adhesion after incuba-
tion in a solution containing FN if they had been rinsed with
PBS or 10% serum prior to cell seeding. These results con-
clusively show that cell adhesion on SAM-modiﬁed sub-
strates is mediated by FN adsorption, and that FN adsorption
to substrates can be controlled by modiﬁcation of the sub-
strates with mixed methyl and oligoethylene glycol-
terminated SAMs. This can be attributed to the reversible
nature of the FN adsorption to EG3-terminated SAMs,
whereas FN irreversibly adsorbs to CH3-terminated SAMs.
Given the effect of SAMs on the adsorption of FN, and
consequently on cell adhesion, we set out to modify the oli-
goethylene glycol terminated monolayers with speciﬁc
peptide sequences in a controlled manner. It was envisaged
that immobilization of a FN fragment from the self-assembly
domain onto substrates with a protein adsorption-resistant
background would provide opportunities to promote the
complex processes involved in the cell-mediated assembly of
FN and COL matrices relevant to the development of new
biomaterials.121 Gold substrates were modiﬁed with a 19:1
ratio of alkanethiols presenting triethylene glycol and a
hexaethylene glycol bearing a carboxylic acid at the ter-
mini, EG6–COOH, Fig. 4A. The carboxylic acid group was
subject to activation with 1-ethyl-3-3-dimethyl-
aminopropylcarbodi-imide hydrochloride EDC and
N-hydroxysuccinimide NHS, Fig. 4B, which affords the
opportunity to tether peptides via amidation of the N termi-
nus or amino side chains, Fig. 4C. Three peptides were
tethered to separate substrates using this EDC/NHS coupling
chemistry: i the short peptide sequence FN13 KGGGA-
HEEICTTNEGVM, which is from the self-assembly do-
main of FN and included a KGGG spacer sequence and
promotes formation of FN ﬁbrils that subsequently mediate
cell adhesion,122 proliferation, and differentiation; ii a short
RGD-containing peptide sequence, GRGDSPC “RGD”,
which promotes cell adhesion; and iii a scrambled FN13
sequence, KGGGITCETNEGEVAMH, to act as a control.
This allowed for presentation of speciﬁc peptide sequences
on a protein adsorption-resistant background.
FIG. 4. Color online A Gold surfaces modiﬁed with EG3 presenting a terminal hydroxyl group and EG6–COOH. B Activation of the carboxylic acid using
EDC/NHS coupling chemistry. C Peptide tethered to EG6–COOH.
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Cells were seeded on substrates presenting peptide se-
quences and the assembly of the FN matrix was studied. FN
which is assembled into high molecular weight multimers is
not soluble in deoxycholate DOC detergent, providing us
with an assay of the assembly process. Substrates modiﬁed
with FN13 showed ten times more DOC insoluble FN than
controls in which cells were seeded on unmodiﬁed sub-
strates, indicating that substrates presenting FN13 enhance
FN matrix assembly. Substrates modiﬁed with the scrambled
FN13 sequence, or RGD alone, showed signiﬁcantly less as-
sembled FN. Accordingly, presentation of the FN13 fragment
on the bioresistive EG3 monolayer provides a method for the
selective deposition and assembly of FN matrices. The den-
sity of FN13 presented on surfaces was determined by ellip-
sometry, and surfaces were modiﬁed with varying densities
of FN13 to study the effects of peptide density on FN matrix
assembly. FN matrix assembly was observed on substrates
bearing a density of greater than 8.9 fmol /cm2 of FN13.
Only a minimal basal level of FN assembly was observed at
lower densities of the peptide. Thus, substrates can be engi-
neered to present a critical density of FN13 needed to medi-
ate FN matrix assembly, thereby producing materials for bio-
medical applications that can enhance cell-material
interactions and mediate tissue regeneration and assembly.
Although using FN13 is effective in promoting cell-
mediated assembly of a robust FN matrix, it is not an adhe-
sive peptide and does not enhance initial cell adhesion. Since
initial cell adhesion has been shown to control long-term cell
function,123,124 signiﬁcant efforts have focused on enhancing
cell attachment by the presentation of adhesive ligands on
nonfouling supports. Unfortunately, cell adhesion and com-
plex cellular events are often not elicited by the tripeptide
RGD, which lacks synergistic binding sites which could be
utilized in increasing activity and binding speciﬁcity.58,125,126
Therefore, to increase receptor-ligand speciﬁcity and control
over cell function, a single 50 kDa recombinant fragment of
FN was constructed FNIII7–10 which incorporates both the
RGD sequence and its synergistic PHSRN binding site. This
ligand mimics the spacing and adhesion characteristics of
FN.116 Gold substrates were modiﬁed with SAMs presenting
a 98:2 mol ratio of EG3 and EG6–COOH. Substrates were
modiﬁed using EDC/NHS coupling chemistry with one of
three peptides: GRGDSPC i.e., RGD, an isolated sequence,
FNIII7–10, and GRGDG13PHSRN “RGD-PHSRN,” which
mimics the spacing of RGD and PHSRN in FN. The surface
density of tethered ligands was quantiﬁed using SPR, which
showed that substrates tethered the same density of RGD and
RGD-PHSRN, whereas a tenfold decrease in tethering den-
sity was observed for FNIII7–10, which can be attributed to
the size of the much larger FNIII7–10 ligand.
Cell adhesion studies were performed on gold substrates
with tethered RGD, RGD-PHSRN, and FNIII7–10. After seed-
ing cells on the substrates bearing tethered peptide, the
strength of cell adhesion was tested using a centrifugation
assay to apply a controlled and reproducible range of forces
to cells attached to the substrates. The number of cells that
remain adhered to the surface is taken as an indication of the
strength of adhesion.127,128 Substrates presenting RGD and
RGD-PHSRN peptides showed similar cell detachment pro-
ﬁles, indicating similar adhesion strength to the substrates
presenting these peptides. However, gold substrates with
tethered FNIII7–10 showed increased amounts of cells on the
surface, indicating that they were more tightly adhered. Thus
surfaces presenting FNIII7–10 could be used to enhance cell
adhesion in biomaterial applications.
A series of integrin blocking assays was performed to
determine which integrins are responsible for cell adhesion
onto the peptide modiﬁed substrates. The major integrin re-
ceptors for FN expressed on the immature osteoblastic cells
examined were 51 and v3. When cells were incubated
with an antibody speciﬁc for the 5 subunit, cell adhesion to
substrates modiﬁed with RGD or RGD-PHSRN was unaf-
fected. However, cell adhesion to substrates modiﬁed with
FNIII7–10 was decreased to background levels. Upon incuba-
tion in an antibody speciﬁc for 3, cell adhesion to surfaces
presenting RGD and RGD-PHSRN showed a 75% decrease,
and no appreciable change in cell adhesion was observed on
surfaces modiﬁed with FNIII7–10. These results indicate that
cells adhere to substrates presenting RGD and RGD-PHSRN
primarily through v3 integrins whereas adhesion of cells to
surfaces modiﬁed with FNIII7–10 occurs primarily through
51 integrins, Fig. 5.
To conﬁrm that cell adhesion to FNIII7–10 modiﬁed sub-
strates occurs primarily through 51 integrins and through
v3 integrins on surfaces presenting RGD and RGD-
PHSRN peptides, cells were seeded and incubated for 4 h on
gold surfaces presenting tethered bioligands, and the mode of
cell adhesion was determined using integrin staining and by
staining for vinculin, a protein found in focal adhesions. Sur-
faces presenting RGD and RGD-PHSRN showed low levels
of focal adhesions containing vinculin and staining for v3
integrins. In contrast, surfaces with tethered FNIII7–10
showed increased staining for 51 integrin compared to
v3 integrins, and greater vinculin staining was observed
compared to surfaces modiﬁed with RGD or RGD-PHSRN.
Cell adhesion to substrates is also controlled in part by
focal adhesions, which are protein complexes that are re-
sponsible for cell signaling and cell adhesion to substrates.
Studies to control the size and position of focal adhesions
were performed in order to determine how they affect the
adhesive strength of cells to patterned gold substrates.115
Gold surfaces were modiﬁed using microcontact printing by
stamping an unfunctionalized alkanethiol as 2, 5, or 10 m
circular spots. The hydrophobic alkanethiol allows protein
adsorption and cell adhesion. The open spaces were then
backﬁlled with EG3, which resists adsorption. Cells seeded
onto this patterned substrate remained circular and were
present only on the methyl-terminated alkanethiol regions.
The focal adhesions were visualized using immunoﬂuores-
cence staining which showed that cells patterned on surfaces
within the 10 m circles had distinct ﬂanges with clustered
integrins; no integrins were observed in areas near the center
of the pattern. For the smaller circles, cells remained circular
and no distinct protrusions were observed, similarly there
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was a uniform distribution of focal adhesions within the
cells. However, a larger amount of cytoskeletal proteins,
which are needed to maintain the cell shape, were clustered
around the edges of the cells.
The adhesive strength of cells to the modiﬁed gold sub-
strates was measured using a spinning disk. As the size of the
micropattern increases the cell adhesion strength also in-
creases. For example, cells patterned on 5 m circles re-
quired twice the force to detach them compared to cells pat-
terned on 2 m circles. However, the 10 m pattern
showed only a 20% increase in adhesion strength over the
5 m patterned circles, indicating that the increase in adhe-
sion strength may plateau, which can be ascribed to integrin
clustering and formation of focal adhesions.129
Thus deposition of SAMs provides an excellent model
system to tailor substrates in order to resist or direct protein
adsorption and cell adhesion. However, gold substrates are
poor choices for the development of implantable biomateri-
als, and SAMs suffer from limited stability.68,69,71 Accord-
ingly, our attention was drawn to the development of robust
hydrophobic polymer brushes on titanium substrates that
could be further modiﬁed by immobilization of peptides.
III. POLYMER BRUSHES FOR INTERFACIAL
ENGINEERING IN BIOLOGICAL APPLICATIONS
A. Introduction
Polymer brushes are assemblies of polymer chains in
which one end of the chain is tethered to a surface. The
preparation of polymer brushes allows for the design of ro-
bust and functional surface coatings.130 Gold, silver, silicon,
glass, and titanium80,83,84,131–133 substrates have been modi-
ﬁed with polymer brushes for an assortment of medical ap-
plications such as diagnostics, cell culture, tissue engineering
scaffolds, intraocular lenses, sutures, and orthopaedic
applications.134–136 These polymer brushes provide func-
tional and durable coatings which may be tailored to enhance
integration of biomaterials with a host. Table I contrasts the
advantages and disadvantages of SAMs and polymer
brushes.
The formation of polymer brushes is achieved through
either a “grafting to” or a “grafting from” approach. The
selective physisorption of one block of a copolymer consti-
tutes a grafting to approach, but given the reversible nature
of physisorption it is desirable to use a polymer bearing
functional groups which couple to complementary function-
ality on the substrate to form a covalent bond. Grafting to
approaches are limited by steric hindrance; after a few poly-
mer chains attach to the substrate, they impede further at-
tachment by blocking access to remaining binding sites on
the surface. This often leads to thin, loosely packed layers of
polymer chains, Fig. 6A.85
A ‘‘grafting from’’ approach in which functional groups
on the substrate are used to initiate chain growth polymer-
izations can be used to obtain a higher density of polymer
chains on a substrate, Fig. 6B.70,80,133 Growth of the poly-
mer chains from the surface relies on the diffusion of small
monomers to the propagating chain end, which is less sus-
ceptible to steric hindrance than diffusion of a preformed
polymer as in the grafting to approaches, Fig. 6A. Grafting
from relies on the introduction of functional groups on the
surface to initiate the polymerization of monomers. Poly-
meric substrates can be functionalized by plasma and glow
discharge in the presence of O2 or N2. However, this method
is not general enough for functionalization of substrates such
as metals and inorganics which are of technological impor-
FIG. 5. Color online A Integrin binding to adhesion sequences presented on substrate surfaces. B Antibodies that bind to a speciﬁc integrin prevent
adhesion of cells through that integrin.
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tance, and this method affords little control over the density
of functional initiating groups. A more attractive approach is
to decorate the solid substrate with a SAM of an initiator-
bearing adsorbate. This approach is extremely ﬂexible, with
the development of synthetic approaches which make use of
cationic,137,138 anionic,139 controlled radical, and ring-
opening polymerizations ROPs e.g., ring opening of lac-
tide monomers and ring-opening metathesis polymerization
of cyclic alkenes.140–147 Of these methods, controlled radical
polymerization of vinyl monomers affords a diverse array of
methods to prepare new functional surfaces. These include
atom transfer radical polymerizations ATRPs from alkyl
halides,148–151 nitroxide-mediated polymerizations
NMPs,151 and reversible addition-fragmentation chain
transfer polymerizations from benzyl
N ,N-diethyldithiocarbamates.152,153
ATRP is a particularly attractive approach for the prepa-
ration of polymer brushes. It is a living polymerization and
allows for control of molecular weight and molecular weight
distribution and affords the opportunity to prepare block co-
polymers. Surface-initiated ATRP SI-ATRP of methyl
methacrylate was ﬁrst reported from well-deﬁned molecular
monolayers formed on glass substrates by Langmuir–
Blodgett transfer of an amphiphilic benzyl chloride.70
Surface-initiated ATRP from an -bromo ester terminated
trichlorosilane SAM on silicon was reported by Matyjasze-
wski et al.,154 which was soon followed by polymerization
from similarly substituted alkanethiol monolayers formed on
gold.70,85,105 SI-ATRP also provides the opportunity to use a
variety of monomers and to tailor the composition and thick-
ness of the brushes by variation of the surface density of
initiating end groups, monomer concentration, and polymer-
ization time.70 The brush density can be controlled by using
a mixed SAM consisting of an ATRP initiator and an unfunc-
tional coadsorbate.
The potential to form two-dimensional gradients155–157
and micron-scale patterns158–161 of initiator-substituted ad-
sorbates, together with control of the composition of the ﬁlm
by block copolymerization using a variety of polymerization
methods162–164 and monomers, affords a high level of control
over the structure and functionality of polymer brushes,
which allows for tailoring of the brushes for a wide variety
of applications.
B. Polymer brushes in the design of biomaterials
Hydrophilic oligoethylene glycol substituted polymer
brushes have been prepared on gold and silicon substrates to
test their ability to resist protein adsorption and cell adhe-
sion. SAMs of adsorbates bearing a bromoisobutyryl group
at the termini have been used to initiate ATRP of oligoeth-
ylene glycol methacrylate OEGMA monomer.70,85,165
Similar to polyethylene glycol and SAMs of EGn on gold,
the polyOEGMA polymer brushes prevent protein adsorp-
tion. Extensive studies of the SI-ATRP of OEGMA polymer
brushes on silicon and gold substrates indicate that the length
TABLE I. Comparison of the advantages and disadvantages of using SAMs and polymer brushes to control surface properties.
Self-assembled monolayers Polymer brushes
Advantages





Molecularly well-deﬁned layers • grafting to
End groups used to tailor surface properties, subject to
modiﬁcation with biological ligands
Tunability through choice of monomer or comonomers
e.g., acrylates and styrenes
Variety of polymerization methods SI-ATRP, ROP, NMP, cationic,
anionic
Greater ﬁlm thickness; control over brush length
Thick ﬁlm might provide self-healing of defects
Disadvantages Thin: one molecular layer More complex preparation
Limited long-term stability More complex structure
Presence of pinholes and defects
FIG. 6. Color online A A substrate modiﬁed by a grafting to approach in
which the initially adsorbed polymer impedes further deposition resulting in
a low density of brushes. B Modiﬁcation of a substrate by a grafting from
approach in which an initiator-bearing substrate is exposed to monomer to
afford thick, dense polymer brushes.
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of the polymer brushes increases linearly with time and that
the brush ﬁlm must be at least 100 Å thick in order for
optimal prevention of protein adsorption.70,85 Similarly, poly-
mer brushes formed by surface-initiated nitroxide-mediated
polymerization of OEG-substituted styrene imparts bioresis-
tance to silicon substrates.132
Messersmith and co-workers used a catechol initiator on
titanium substrates to perform SI-ATRP of OEGMA.83,133
The polyOEGMA brushes resisted protein adsorption and
cell adhesion for up to 5 weeks. However, the poly-
OEGMA brushes in these studies presented a terminal me-
thyl group. The lack of chemical functionality of the brushes
prevented further modiﬁcation with bioactive peptides that
might be used to elicit speciﬁc biological responses.
Titanium and its alloys are used extensively for hip and
knee joint replacements, as well as in dental and cardiac
pacemaker implants. Current titanium implants still suffer
from limited integration into the surrounding bone osseoin-
tegration which ultimately results in loosening and wear,
thereby requiring revision surgery.166,167 Initial attempts to
address these limitations focused on physically roughening
the titanium surface, but these methods to enhance osseoin-
tegration had limited success.166,168 This led us to explore a
possible role for polymer brushes in developing strategies to
control the adsorption of proteins and adhesion of cells on
titanium substrates. Based on the demonstrated ability to
control protein adsorption on model systems consisting of
SAMs, we sought to enhance the osseointegration of tita-
nium through decoration of the metal surface with polymer
brushes that retain chemical functionality that can be used to
immobilize bioligands. Our approach makes use of the SI-
ATRP of bioresistive polymer brushes followed by covalent
attachment of peptides that signal for cell adhesion and os-
teoblast differentiation.169
C. Modiﬁcation of titanium with oligo„ethylene glycol…
methacrylate polymer brushes to control cell
adhesion
In order to improve on approaches to control cell adhe-
sion by physisorption of peptides onto metallic
substrates133,139,165 we envisaged that SI-ATRP of OEGMA
could be used to form a protein adsorption-resistant i.e.,
nonfouling polymer brush system, and that tethering spe-
ciﬁc peptide sequences to the brushes would allow us to
provide signals for cell adhesion and function.80 Thus, this
approach would prevent the nonspeciﬁc adsorption of pro-
teins from the biological matrix onto the implant, and en-
hance selective cell deposition, differentiation, and prolifera-
tion. We expect that this approach can be developed so as to
promote greater bone growth on the surface, thereby provid-
ing a stronger bond between the bone and implant.
PolyOEGMA brushes were deposited on a SAM of a
dimethylchlorosilane presenting a terminal -bromo ester
that was used to initiate SI-ATRP of OEGMA to afford poly-
OEGMA brushes, Figs. 7A and 7B. In this case, the
OEGMA side chains had a terminal hydroxyl group, which
are amenable to modiﬁcation with 4-nitrophenyl chlorofor-
mate NPC to produce a 4-nitrophenyl carbonate linkage,
Figs. 7B and 7C. The N terminus or an amino side chain
of a peptide displaces 4-nitrophenol, thereby forming a new
urethane linkage and immobilizing the peptide on the sur-
face, Fig. 7D.
The surface modiﬁcation of titanium outlined in Fig. 7
was monitored using specular reﬂection Fourier-transform
infrared spectroscopy FTIR. The carbonyl absorbance for
titanium substrates modiﬁed with the bromoisobutyryl initia-
tor 1738 cm−1 shifted to 1730 cm−1 and increased in in-
tensity upon SI-ATRP of OEGMA, corresponding to the
deposition on the methacrylate polymer. Modiﬁcation of the
FIG. 7. Color online A Formation of a mixed SAM by treatment of
oxidized titanium with a monochlorosilane bearing a terminal bromoisobu-
tyrate for initiation of SI-ATRP of OEGMA. B PolyOEGMA brushes
with terminal hydroxyl groups. C Modiﬁcation of the hydroxyl groups
with NPC. D Peptide tethering to the modiﬁed hydroxyl end groups of the
polyOEGMA brushes.
FA10 Raynor et al.: Controlling cell adhesion to biomaterials FA10
Biointerphases, Vol. 4, No. 2, June 2009
hydroxyl end groups of the polyOEGMA brushes with
NPC resulted in the appearance of a second carbonyl absor-
bance at 1770 cm−1, which can be attributed to the carbonate
linkage. Upon the subsequent treatment with GFOGER, the
FTIR spectrum showed a new absorbance at 1668 cm−1 due
to the amide linkages. The ability of titanium substrates
modiﬁed with polyOEGMA brushes to resist peptide ad-
sorption and the ability of NPC modiﬁed brushes to tether
peptide were studied using SPR. The polyOEGMA brushes
modiﬁed with NPC tethered seven times more GFOGER
27.8 pmol /cm2 through formation of a covalent linkage
than unmodiﬁed polyOEGMA brushes, which can only ad-
sorb peptide by physisorption. In the latter case most of the
peptide could be rinsed from the surface, whereas the co-
valently bound peptide persisted even after rinsing with sur-
factant solution. The effect of tethered peptide on cell adhe-
sion was explored with ﬂuorescently dyed MC3T3-E1
osteoblast-like cells. Cells rapidly adsorb on unmodiﬁed ti-
tanium with an oxide surface to form a conﬂuent layer,
whereas substrates presenting polyOEGMA brushes re-
sisted cell adhesion for up to 56 days. Covalent modiﬁcation
of the polyOEGMA brushes with GFOGER enhanced cell
adhesion. Thus modiﬁcation of titanium substrates with poly-
OEGMA brushes afforded a nonfouling background to
which a speciﬁc peptide could be tethered to control cell
adhesion.
The ability to successfully tether biomolecules to poly-
OEGMA brushes on titanium substrates was extended to
examine the effect of a variety of immobilized peptides on
adhesion and enhance osteoblast differentiation. Brushes
were modiﬁed with different densities of either GRGDSPC
RGD, a linear peptide sequence containing the ubiquitous
adhesion sequence, or FNIII7–10, a recombinant fragment of
FN that presents both the RGD sequence and its PHSRN
synergy site. Titanium substrates were modiﬁed with poly-
OEGMA brushes, treated with NPC, and incubated in in-
creasing concentrations of peptide to determine the maxi-
mum tethering density of the ligands. The maximum peptide
tethering densities were determined by SPR as approxi-
mately 6000 fmol /cm2 for RGD and 1000 fmol /cm2 for
FNIII7–10. The difference in the density of tethered peptide
can be attributed to the relative size of the ligands. An anti-
body assay that mimics receptor-ligand binding was per-
formed to demonstrate that the ligands are accessible and
active on the surfaces. PolyOEGMA brushes presenting
FNIII7–10 that were incubated in ﬂuorescently labeled anti-
body show increasing ﬂuorescence for higher densities of
tethered peptide, indicating that the peptide is present in its
active form. Unmodiﬁed brushes showed only background
levels of ﬂuorescence.
D. Assays of cell adhesion and function on peptide
modiﬁed poly„OEGMA… brushes
Integrin binding assays were conducted using titanium
substrates modiﬁed with polyOEGMA brushes with teth-
ered with equimolar densities of RGD or FNIII7–10. Cells
were incubated in a solution containing antibodies for the 5
or v integrin, thereby blocking their ability to bind to do-
mains present in surface-immobilized peptides. Cell adhe-
sion on polyOEGMA bearing FNIII7–10 in the presence of
5-blocking antibodies was minimal, indicating that cells ad-
here to immobilized FNIII7–10 through the 51 integrin re-
ceptor. Cells that were incubated in an anti-v antibody do
adhere to substrates presenting FNIII7–10. In contrast, cells
incubated with an anti-v antibody do not adhere to RGD
tethered to brushes, thereby verifying that the v3 integrin
is necessary for cell adhesion to substrates presenting RGD.
Focal adhesion kinase FAK phosphorylation after 7 days
was studied as an indicator of cell signaling. Analysis of the
site of FAK phosphorylation in cells on different substrates
allowed us to determine the potential inﬂuence of the surface
modiﬁcations on intracellular signaling, speciﬁcally for path-
ways involving integrin signal transduction and osteogenic
differentiation.170,171 Antibodies were used that are speciﬁc
for three phosphorylated i.e., activated tyrosine residues of
FAK: i Y397, which is important in differentiation and os-
teogenic pathways; ii Y576, which is located in the cata-
lytic portion of the FAK protein, resulting in maximal cata-
lytic activity when it is phosphorylated and thereby priming
pathways for osteogenic differentiation; and iii Y861,
which affects proliferation and differentiation of cells. Ex-
periments were performed on four substrates: unmodiﬁed ti-
tanium, titanium modiﬁed with polyOEGMA brushes, and
titanium with RGD or FNIII7–10 tethered to polyOEGMA
brushes. Increased levels of phosphorylated FAK Y397 and
Y576 were observed in cells seeded on surfaces with teth-
ered FNIII7–10, corresponding to an increase in indicators for
osteoblast differentiation. In contrast, elevated levels of
Y861 phosphorylation were observed in cells on unmodiﬁed
titanium and for surfaces presenting RGD.
To further establish that binding to the modiﬁed surfaces
controls signaling, cells were incubated with anti-5 anti-
body which prevents cell adhesion to substrates presenting
FNIII7–10, see above and seeded onto modiﬁed substrates.
Substrates modiﬁed with FNIII7–10 showed decreased levels
of Y397 and Y576 phosphorylation, whereas no changes in
phosphorylation were seen on the substrates modiﬁed with
RGD or on serum-exposed titanium. These results demon-
strate that the 51 integrin selectively binds to FNIII7–10
and is primarily responsible for FAK phosphorylation of
Y397 and Y576.
Cells incubated in a solution of antibody speciﬁc for 3
and seeded onto RGD-tethered substrates showed lower lev-
els of FAK phosphorylation. This indicates that binding of
the 3 integrin to RGD is responsible for regulation of phos-
phorylation of Y861. Thus, these results show that cells in-
cubated on polyOEGMA brushes with tethered FNIII7–10
show differential cell signaling and, moreover, increased lev-
els of osteoblast-related signaling markers compared to those
on unmodiﬁed titanium substrates or on polyOEGMA
brushes with tethered RGD. Thus, the surface-immobilized
adhesion sequences not only increase cell adhesion but also
exert control over more downstream cellular function.
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E. Osteoblastic differentiation assays on peptide
modiﬁed poly„OEGMA… brushes
Assays were conducted to determine if the bioligands
tethered to the polyOEGMA brushes stimulated expression
of markers that are associated with osteoblast differentiation.
Unmodiﬁed titanium, titanium substrates modiﬁed with poly-
OEGMA brushes, and polyOEGMA brushes with teth-
ered RGD or FNIII7–10 were seeded with rat bone marrow
stromal cells for 7 days. Gene expression was assessed using
reverse transcription polymerase chain reaction for the
Runx2/Cbfa1 transcription factor, which is necessary for
bone formation,172 and the late osteoblastic markers osteocal-
cin OCN and bone sialoprotein BSP. Surfaces with teth-
ered FNIII7–10 showed elevated levels of Runx2/Cbfa1,
OCN, and BSP compared to the other surfaces, indicating
enhanced osteoblast differentiation on these substrates. In ad-
dition, alkaline phosphatase activity was increased on sur-
faces functionalized with FNIII7–10, which also is indicative
of enhanced osteoblast differentiation.
Matrix mineralization was determined using an end-point
functional marker, calcium incorporation. This analysis
showed two times more mineralization on titanium substrates
with tethered FNIII7–10 to polyOEGMA brushes compared
to titanium substrates with RGD tethered to polyOEGMA
brushes.
Taken together these results show enhanced osteoblast
differentiation in primary bone marrow stromal cells cultured
on titanium substrates modiﬁed FNIII7–10 tethered to poly-
OEGMA brushes. This further illustrates the ability to use
our molecularly engineered surface architectures to direct
cell function in a manner relevant to the design enhanced
bone implants.
F. In vivo osseointegration of peptide modiﬁed
poly„OEGMA… brushes
The increase in osteoblast differentiation on substrates
modiﬁed with FNIII7–10 tethered to polyOEGMA brushes
observed in vitro was promising for the development of new
bioactive materials. Accordingly, in vivo studies were con-
ducted to examine the effectiveness of these surfaces in rig-
orous animal models. Custom-made clinical grade titanium
cylinders were modiﬁed with either unmodiﬁed poly-
OEGMA brushes or RGD or FNIII7–10-tethered brushes.
The cylinders were press ﬁtted into 2.0 mm diameter holes in
the proximal tibial metaphyses of mature Sprague–Dawley
male rats. After 4 weeks of implantation the tibiae were har-
vested. Osseointegration was analyzed by histomorphometry,
and implant mechanical ﬁxation was determined by measure-
ment of pull-out force.
Histomorphometric analyses were performed to determine
the contact area between the implant and bone. Titanium
cylinders with FNIII7–10 tethered to polyOEGMA brushes
had more bone tissue around the implant compared to all
other surfaces, with a 70% increase in bone contact area
compared to unmodiﬁed titanium, the current clinical stan-
dard orthopedic implant material, Fig. 8A. The mechanical
ﬁxation of the implants was tested using a pull-out test, in
which the force required to remove the implant was deter-
FIG. 8. Color online A Cross section view of titanium implant with peptide tethered to polyOEGMA brushes in rat tibia. B Cross section view of
titanium implant modiﬁed with polyOEGMA brushes. C Pull-out forces required to removed implants with various surface treatments from rat tibiae. From
Ref. 177. Copyright © 2008 by from Elsevier. Reprinted and modiﬁed in part by permission of Elsevier. D Schematic of apparatus used to determine the
pull-out force.
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mined, Fig. 8B. Again, titanium cylinders modiﬁed with
polyOEGMA brushes presenting FNIII7–10 outperformed
unmodiﬁed titanium. Notably, removal of the implants modi-
ﬁed with FNIII7–10 from bone required a greater force than
unmodiﬁed titanium, Fig. 8C. The polyOEGMA brushes
and RGD-tethered brushes required lower pull-out forces,
consistent with the results of in vitro bioassays.
Thus, in vitro studies of titanium substrates modiﬁed with
ligands tethered to polyOEGMA brushes selectively en-
hance cell adhesion and osteoblast differentiation of rat bone
marrow stromal cells. Polymer brushes presenting FNIII7–10
provides greater binding speciﬁcity and shows increased os-
teoblast differentiation than substrates presenting a short im-
mobilized RGD sequence. In vivo studies using titanium cyl-
inders modiﬁed with polyOEGMA brushes presenting
FNIII7–10 show enhanced osseointegration compared to un-
modiﬁed titanium polyOEGMA brushes bearing RGD.
These encouraging results motivated continued exploration
of our strategy to present selected peptides on bioadhesion-
resistant hydrophilic brushes for the development of im-
FIG. 9. Color online Synthesis of polyGAMA brushes, modiﬁcation of hydroxyl end groups with NPC, and peptide tethering.
FIG. 10. Color online Enzyme-linked immunosorbent assay of polyOEGMA brushes after long-term incubation in buffer or media showed little peptide
adsorption. PolyGAMA brushes showed an increase in peptide adsorption upon 1 week incubation in buffer, and upon incubation in media polyGAMA
brushes showed a signiﬁcant increase in peptide adsorption compared to polyOEGMA brushes.
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proved orthopedic implant materials Sec. IV.
IV. CONCLUSIONS AND PERSPECTIVES
The use of self-assembled monolayers and polymer
brushes affords strategies to provide control over protein ad-
sorption and cell adhesion on biomaterials. Deposition of
SAMs of EG3 on gold and polyOEGMA brushes on tita-
nium imparts resistance to nonspeciﬁc adsorption of pro-
teins. Covalent immobilization of adhesion peptides to the
bioresistive surfaces presents opportunities to elicit speciﬁc
cell adhesion and responses. While SAMs of alkanethiols on
gold are well suited as models for analyses of the effects of
surface modiﬁcations on bioadhesion, we have advanced our
study of peptide modiﬁed polyOEGMA brushes on tita-
nium to in vivo experiments. PolyOEGMA brushes pre-
senting the FNIII7-10 fragment bind cells primarily via the
51 integrin and promote osteoblast differentiation. En-
hanced osseointegration of titanium implants with rat tibiae
was demonstrated in a rigorous animal model. Greater den-
sity of new tissue growth around the modiﬁed substrate re-
sults in a stronger mechanical union between the implant and
bone. Thus, the molecular-scale interfacial engineering of
biomaterials presents an attractive pathway toward the de-
sign of enhanced orthopedic implants.
In addition to their use in medical implants, the use of
polymer brushes might be extended to other bioapplications
such as biosensors. This approach could be used to overcome
problems of biofouling of optical and electronic sensing sur-
faces by nonspeciﬁc adhesion of proteins and cells. This ad-
sorption may be mitigated by providing a nonfouling back-
ground bearing selected proteins, peptides, or antigens to
bind to speciﬁc components present in a complex mixture.
To achieve this goal, polyOEGMA brushes that resist non-
speciﬁc protein adsorption could be used to coat sensor chips
and, as we have demonstrated, the hydroxyl end groups of
the brushes could then be modiﬁed to tether speciﬁc
bioligands.173 For example, in a demonstration of this prin-
ciple, immunoglobin IgG has been immobilized on the
NHS-bearing polyOEGMA brushes on silicon
substrates.174 This was explored as a prototype for a sensor
based on binding of ﬂuorescently labeled anti-IgG antibody
in a micropatterned array.175
Given the successful demonstration that polyOEGMA
brushes resist in vitro and in vivo adsorption of proteins and
that immobilization of speciﬁc adhesion sequences can be
used to promote cell adhesion and functions, we have re-
cently extended this approach to explore the surface modiﬁ-
cation of titanium with saccharide-based polymer brushes.
SI-ATRP of the 2-gluconamidoethyl methacrylate GAMA
monomer on titanium substrates176 affords polyGAMA
brushes which are subject to modiﬁcation with peptides, Fig.
9. The brushes exhibit increased resistance to protein and cell
adhesion in short-term experiments i.e., 1 h incubation of
substrates in media with cells. However, resistance was lost
in our initial long-term cell adhesion studies in which po-
lyGAMA brushes were incubated in serum-containing me-
dia for 1 week and then exposed to cells. The loss of resis-
tance to adhesion from incubation in serum-containing media
might be attributed to adsorption of proteins or to degrada-
tion of the brushes. To examine these mechanisms, titanium
substrates modiﬁed with polyGAMA brushes and poly-
OEGMA brushes were incubated in either serum-
containing media or serum-free buffer which contained a
biotin-substituted GFOGER peptide. An enzyme-linked im-
munosorbent assay ELISA was performed with an antibody
speciﬁc for biotin. Substrates modiﬁed with either type of
polymer brush, incubated for 1 h in either media or buffer
containing biotinylated GFOGER, showed only low levels of
adsorbed peptide. However, after a 1 week incubation, poly-
OEGMA brushes still showed only low levels of GFOGER
adsorption and the polyGAMA brushes incubated in buffer
showed a higher level of adsorption a much greater amount
of peptide adsorbed to polyGAMA brushes on titanium-
modiﬁed substrates incubated in media, Fig. 10. Assuming
that the increase in peptide adsorption could be correlated
with an increase in protein adsorption over time, this ex-
plains the enhanced cell adhesion observed in long-term
studies.
The approaches outlined in this review provide strong
motivation to further extend the use of molecularly designed
interfaces for biological applications and to assess the long-
term in vivo performance for these engineered coatings.
These approaches lend themselves to application in a number
of technologies including sensing, enhanced tissue repair,
and other regenerative medicine. We anticipate that such mo-
lecular approaches to interfacial engineering will provide
broadly applicable platforms for the reduction of nonspeciﬁc
biological reactions and the controlled presentation of bioad-
hesive motifs to elicit directed cellular responses.
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